Full-Time

Infusion Nurse RN

Posted on 10/4/2025

AdaptHealth

AdaptHealth

1,001-5,000 employees

Home medical equipment provider with rentals

No salary listed

Toms River, NJ, USA

In Person

Category
Medical, Clinical & Veterinary (1)
Requirements
  • Graduate of an accredited School of Nursing.
  • Two (2) years nursing experience in a hospital or similar setting required.
  • Must have a valid and unrestricted driver’s license.
  • Must have a valid and unrestricted RN license from the state in which he/she would be practicing.
  • Current CPR certification.
Responsibilities
  • Makes initial visits, processes orders, notifies physician of patient needs and changes in condition.
  • Initiates care completes certification/recertification orders, and discharge summaries, if required.
  • Regularly re-evaluates needs of the patients.
  • Counsels with the patient and family/significant others on nursing, teaching, and related needs.
  • Inserts intravenous cannulas; teaches and or administers prescribed intravenous solutions, medications, and biological products; monitors and maintains infusion sites and systems; evaluates response to prescribed therapy.
  • Informs the physician and personnel of changes in the condition and needs of the patient.
  • Initiates appropriate preventative and rehabilitative nursing procedures.
  • Provides those services requiring substantial specialized nursing skills.
  • Prepares clinical records, care plans, progress notes for each patient visit and summaries of care conferences on his/her patients in a timely manner per company policy.
  • Provides case management along with the pharmacist to enhance patient outcomes.
  • Identifies nursing diagnosis/patient care problems and interventions making additions/changes to ensure the patient’s problems are comprehensively addressed to avoid rehospitalization.
  • Initiates and or coordinates the plan of care to include other disciplines as needed and act as a case manager to ensure integration of care is provided.
  • Assesses the patient’s environment with particular attention to safety to ensure the environment is suitable for the delivery of safe and effective care.
  • Participates in in-services programs and presents in-service programs.
  • Conducts patient care conferences on patients assigned to his/her care.
  • Attends all patient care conferences and meetings as scheduled.
  • Participates in peer review and performance improvement as assigned.
  • Participates in review of clinical records as assigned.
  • Assume on-call responsibilities during non-business hours in accordance with company policy.
  • Maintain patient confidentiality and function within the guidelines of HIPAA.
  • Complete assigned compliance training and other educational programs as required.
  • Maintain compliant with AdaptHealth’s Compliance Program.
  • Perform other related duties as assigned.
Desired Qualifications
  • Two (2) years of infusion therapy experience. Preferred
  • CRNI credential preferred.

AdaptHealth provides home medical equipment and related services to support patients living outside of hospitals. It sells and rents devices such as wheelchairs, ventilators, CPAP machines, thermometers, pulse oximeters, and sanitizing equipment, and also offers resupply and ongoing support; equipment is delivered, installed, maintained, and restocked as needed. The company serves patients, healthcare professionals, and insurance companies by coordinating direct sales, rentals, and insurance partnerships to ensure continuous home-based care. Its goal is to empower patients to live life at home with accessible, coordinated equipment and care.

Company Size

1,001-5,000

Company Stage

IPO

Headquarters

Phoenixville, Pennsylvania

Founded

2012

Simplify Jobs

Simplify's Take

What believers are saying

  • A five-year capitated contract should add about $200 million recurring revenue annually.
  • Thirty-five new locations support the 10 million-member patient transition.
  • The April 2026 refinancing extends maturities to 2031 and lowers debt costs.

What critics are saying

  • Rotech's Sequoia acquisition intensifies competition in sleep and CPAP resupply.
  • The 10 million-member contract creates execution risk across claims, service, and staffing.
  • AdaptHealth remains levered, so EBITDA misses quickly pressure cash flow and valuation.

What makes AdaptHealth unique

  • AdaptHealth serves 4.5 million patients yearly across 669 locations in 48 states.
  • Its model combines home medical equipment, consumables, and related services.
  • It focuses on sleep apnea, respiratory, diabetes, and mobility care.

Help us improve and share your feedback! Did you find this helpful?

Your Connections

People at AdaptHealth who can refer or advise you

Benefits

Health Insurance

401(k) Retirement Plan

Growth & Insights and Company News

Headcount

6 month growth

0%

1 year growth

-1%

2 year growth

0%
Stock Titan
Apr 13th, 2026
AdaptHealth (NASDAQ: AHCO) extends debt maturities and lowers interest costs.

AdaptHealth (NASDAQ: AHCO) extends debt maturities and lowers interest costs. Filing Impact Filing Sentiment Rhea-AI Filing summary. AdaptHealth Corp. entered into a new senior secured credit facility totaling $1.1 billion, replacing its prior credit arrangements and extending its debt maturity profile. The package includes a $325 million Term Loan A, a $325 million delayed draw term loan, and a $450 million revolving credit facility. Proceeds from the new term loan repaid the existing term loan and prior credit agreement, while the delayed draw facility is intended to redeem the 6.125% Senior Notes due 2028, lowering interest expense. The facility, maturing in April 2031, features lower SOFR-based pricing tied to leverage covenants and is supported by recent credit rating upgrades. The company states the transaction does not change its full-year 2026 guidance. Positive. * The new $1.1 billion senior secured credit facility extends AdaptHealth's debt maturity to April 2031, reduces SOFR-based pricing margins, and is expected to lower weighted average cost of debt by at least 25 bps after redemption of the 6.125% Senior Notes due 2028. Negative. Insights. Refinancing extends debt maturities to 2031 and modestly lowers borrowing costs. AdaptHealth has arranged a $1.1 billion senior secured credit facility, combining a term loan, delayed draw term loan, and revolver. This replaces its prior term loan and smaller revolver, consolidating bank debt under a single agreement with standardized covenants. The company plans to use the $325 million delayed draw term loan to redeem its 6.125% Senior Notes due 2028, once callable at par, which should reduce interest expense. The facility matures in April 2031, roughly two years later than the prior structure, easing near-term refinancing risk. Pricing is now indexed to the Consolidated Total Leverage Ratio, with SOFR margins as low as 1.125%. Management estimates at least a 25 bps reduction in weighted average cost of debt after note redemption. Recent rating upgrades by S&P and Moody's likely supported these terms, and the company indicates its 2026 guidance remains unchanged, framing this as a balance-sheet optimization rather than a shift in operating outlook. 8-K event classification. 5 items: 1.01, 1.02, 2.03, 7.01, 9.01 Key figures. Total new credit facility: $1.1 billion Term Loan A size: $325 million Delayed Draw Term Loan: $325 million +5 more Key terms. Delayed Draw Term Loan, Revolving loan commitments, Consolidated Total Leverage Ratio, Term SOFR, +2 more 04/13/2026 - 08:11 AM Faq. What did AdaptHealth (AHCO) announce regarding its new credit facility? AdaptHealth closed a new $1.1 billion senior secured credit facility. It includes a $325 million Term Loan A, a $325 million Delayed Draw Term Loan, and a $450 million revolving credit facility, replacing its prior term loan and smaller revolver. How will AdaptHealth use the proceeds from the new Term Loan A and Delayed Draw Facility? The $325 million Term Loan A was used to fully repay the company's existing term loan and prior credit agreement. The $325 million Delayed Draw Facility is intended to redeem the 6.125% Senior Notes due 2028 once they become callable at par in August 2026. How does the new AdaptHealth credit facility affect debt maturities? The new senior secured credit facility matures in April 2031, extending AdaptHealth's debt maturity profile by roughly two years. This longer runway reduces near-term refinancing risk and supports the company's ability to pursue its strategic and operational priorities. What interest rate terms apply to AdaptHealth's new credit facility? Borrowings can be based on a base rate or Term SOFR, plus an Applicable Margin. For SOFR loans, the margin ranges from 1.125% to 2.000% per year, determined by the Consolidated Total Leverage Ratio, replacing the company's prior, higher pricing grid. Will AdaptHealth's new financing change its 2026 financial guidance? AdaptHealth states the new $1.1 billion credit facility is not expected to affect its full-year 2026 guidance. Management frames the transaction as a refinancing that improves terms and flexibility, rather than a change in the company's underlying operating outlook. What role did credit rating upgrades play in AdaptHealth's new facility? Recent rating upgrades by S&P Global Ratings and Moody's Ratings recognized improved performance and a stronger balance sheet. AdaptHealth believes these upgrades, plus consistent free cash flow, helped secure a lower pricing grid and favorable terms on the new credit facility. Filing exhibits & attachments. 2 documents Press releases.

MarketScreener
Apr 13th, 2026
AdaptHealth secures $1.1B credit facility with extended maturity to 2031 and 25bps lower debt cost

AdaptHealth Corp., a US provider of home medical equipment and services, has closed a $1.1 billion senior secured credit facility, consisting of a $325 million term loan, a $325 million delayed draw facility and a $450 million revolving credit line. The new facility replaces the company's existing debt arrangements. The refinancing extends AdaptHealth's debt maturity to April 2031, approximately two years beyond the previous facility, whilst reducing borrowing costs. The interest rate pricing grid has been lowered, with the lowest tier falling from 1.50% to 1.125% over SOFR. The company expects its weighted average cost of debt to decrease by at least 25 basis points once its 6.125% senior notes due 2028 are redeemed. The improved terms follow recent credit rating upgrades from S&P Global Ratings and Moody's Ratings.

Investing.com
Mar 31st, 2026
OEP entities purchase $4.4M in AdaptHealth shares at $9.81-$9.95

Entities associated with One Equity Partners have acquired $4.4 million worth of AdaptHealth Corp shares across two transactions. On 19 March 2026, the entities purchased 727 shares at $9.94 per share, followed by 447,100 shares at $9.91 per share on 20 March 2026. The purchases occurred at prices ranging from $9.81 to $9.95. Following these transactions, OEP entities now hold 16,312,698 shares of AdaptHealth. The stock currently trades at $11.29, up nearly 9% over the past week. The transactions come after AdaptHealth reported fourth-quarter 2025 earnings that missed EPS expectations but exceeded revenue forecasts at $846.3 million. RBC Capital maintains an Outperform rating with a $13 price target, whilst Leerink Partners lowered its target to $12.

Yahoo Finance
Feb 24th, 2026
AdaptHealth posts $3.2B revenue with new capitated contract expected to drive 5%-6% growth in 2026

AdaptHealth reported 2025 net revenue of $3.245 billion, down 0.5% on a reported basis but up 1.7% organically, with adjusted EBITDA of $616.7 million representing a 19.0% margin. Full-year free cash flow reached $219.4 million, exceeding guidance. The company launched a new operating model that improved setup times and deployed technology pilots including AI-powered order processing. It went live early on a major capitated contract covering approximately 50,000 members across three Mid-Atlantic states, which management expects could ultimately serve 10 million patients and contribute 5%-6% growth in 2026. For 2026, AdaptHealth guided net revenue of $3.44-3.51 billion, adjusted EBITDA of $680-730 million, and free cash flow of $175-225 million. The company ended 2025 with net debt of $1.694 billion and net leverage of 2.75x.

LebTown
May 14th, 2025
WellSpan Health sells durable medical equipment business to AdaptHealth

WellSpan Health has sold its durable medical equipment business, WellSpan Medical Equipment, to national firm AdaptHealth, effective June 1.

INACTIVE